Ganirelix for luteolysis in poor responder patients undergoing IVF treatment: A Scandinavian multicenter 'extended pilot study'

Acta Obstetricia et Gynecologica Scandinavica

Volumn 89, Issue 6, 2010, Pages 828-831

  Nilsson, Lars ^a   Andersen, Anders Nyboe ^b   Lindenberg, Svend ^c   Hausken, Jon ^d   Andersen, Claus Yding ^e   Kahn, Jarl A ^f  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b Rigshospitalet   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d HAUGESUND HOSPITAL   (Norway)

^e Mental Health Services CPH   (Denmark)

^f Fertility Centre   (Norway)

Author keywords

GnRH antagonist; IVF treatment; Luteolysis; Poor responders

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GANIRELIX; GONADORELIN ANTAGONIST; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG TARGETING; FEMALE; FEMALE FERTILITY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HORMONE RELEASE; HUMAN; LOW DRUG DOSE; LUTEAL PHASE; LUTEOLYSIS; MAJOR CLINICAL STUDY; MENSTRUATION; MULTICENTER STUDY; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARY FOLLICLE DEVELOPMENT; PILOT STUDY; PREGNANCY OUTCOME; PRIORITY JOURNAL; SCANDINAVIA; TREATMENT OUTCOME; TREATMENT RESPONSE;

FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; INFERTILITY, FEMALE; LUTEAL PHASE; LUTEOLYSIS; OVULATION INDUCTION; PILOT PROJECTS; PREGNANCY; PREGNANCY OUTCOME;

EID: 77952919505     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.3109/00016341003721029     Document Type: Article

References (13)

1. Keay SD, Liversedge NH, Mathur ES, Jenkins JM. Assisted conception following poor ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol. 1997;104:521-7.
2. Saldeen P, Källén K, Sundström P. The probability of successful IVF outcome after poor ovarian response. Acta Obstet Gynecol Scand. 2007;86:457-61.
3. Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update. 2003;9:61-76.
4. Anderson R, Kinniburgh T, Baird DT. Preliminary experience of the use of a gonadotrophin releasing hormone antagonist ikn ovulation induction/in-vitro fertilization prior to cancer treatment. Hum Reprod. 1999;14:2665-8.
5. Fridén B, Nilsson L. Gonadotrophin-releasing hormone-antagonist luteolysis during the preceding mid-luteal phase is a feasible protocol in ovarian hyperstimulation before in vitro fertilization. Acta Obstet Gynecol Scand. 2005;84:812-16.
6. Humaidan P, Bungum L, Bungum M, Hald F, Agerholm I, Blaabjerg J, Yding Andersen C, Lindenberg S. Reproductive outcome using a GnRH antagonist (cetrorelix) for luteolysis and follicular synchronization in poor responder IVF/ICSI patients treated with a flexible GnRH antagonist protocol. Reprod Biomed Online. 2005;(11):679-84.
7. van Poppel H, Nilsson S. Testosterone surge: rationale for gonadotropin-releasing hormone blockers? Urology. 2008;71: 1001-6.
8. Wong SL, Lau DT, Baughman SA, Menchaca D, Garnick MB. Pharmacokinetics and pharmacodynamics of abarelix, a gonadotropin-releasing hormone antagonist, after subcutaneous continuous infusion in patients with prostate cancer. Clin Pharmacol Ther. 2003;(73):304-11.
9. Valiente C, Romero GG, Corrada Y, de la Sota PE, Hermo G, Gobello C. Interruption of the canine estrous cycle with a low and a high dose of the GnRH antagonist acyline. Theriogenology. 2009;71:408-11.
10. Malmusi S, La Marca A, Giulini S, Xella S, Tagliasacchi D, Marsella T, Volpe A. Comparison of a gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare-up regimen in poor responders undergoing ovarian stimulation. Fertil Steril. 2005;(84):402-6.
11. Demirol A, Gurgan T. Comparison of microdose flare-up and antagonist multiple-dose protocols for poor-responder patients: a randomized study. Fertil Steril. 2009;92:481-5.
12. Weitzman VN, Engmann L, Diluigi A,Maier D, Nulsen J, Benadiva C. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes. Fertil Steril. 2009;92:226-30.
13. Mohamed KA, Davies WA, Allsopp J, Lashen H. Agonist "flare-up" versus antagonist in the management of poor responders undergoing in vitro fertilization treatment. Fertil Steril. 2005;83:331-5.